0000950103-15-004416.txt : 20150602 0000950103-15-004416.hdr.sgml : 20150602 20150602163030 ACCESSION NUMBER: 0000950103-15-004416 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20150602 DATE AS OF CHANGE: 20150602 EFFECTIVENESS DATE: 20150602 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biotie Therapies Corp. CENTRAL INDEX KEY: 0001579695 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: H9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-240976 FILM NUMBER: 15907231 BUSINESS ADDRESS: STREET 1: JOUKAHAISENKATU 6 CITY: TURKU STATE: H9 ZIP: FI-20520 BUSINESS PHONE: 358-2-274-8900 MAIL ADDRESS: STREET 1: JOUKAHAISENKATU 6 CITY: TURKU STATE: H9 ZIP: FI-20520 D 1 primary_doc.xml X0707 D LIVE 0001579695 Biotie Therapies Corp. JOUKAHAISENKATU 6 TURKU H9 FINLAND FI-20520 358-2-274-8900 FINLAND None None Corporation true Timo Veromaa JOUKAHAISENKATU 6 TURKU H9 FINLAND F1-20520 Executive Officer David Cook JOUKAHAISENKATU 6 TURKU H9 FINLAND F1-20520 Executive Officer Stephen Bandak 701 GATEWAY BOULEVARD SUITE 350 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Executive Officer Medhi Paborji 701 GATEWAY BOULEVARD SUITE 350 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Executive Officer Williams Burns JOUKAHAISENKATU 6 TURKU H9 FINLAND F1-20520 Director Merja Karhapaa JOUKAHAISENKATU 6 TURKU H9 FINLAND F1-20520 Director Bernd Kastler JOUKAHAISENKATU 6 TURKU H9 FINLAND F1-20520 Director Ismail Kola JOUKAHAISENKATU 6 TURKU H9 FINLAND F1-20520 Director Guido Magni JOUKAHAISENKATU 6 TURKU H9 FINLAND F1-20520 Director Don Matthew Bailey JOUKAHAISENKATU 6 TURKU H9 FINLAND F1-20520 Director Mahendra G Shah JOUKAHAISENKATU 6 TURKU H9 FINLAND F1-20520 Director Biotechnology $5,000,001 - $25,000,000 06c false 2015-05-28 false true true false 544800 16344000 6058176 10285824 Amounts in Item 11 and Item 13 use an exchange rate of EUR 1 to USD 1.0896 (as reported by the ECB on May 28, 2015). Total Remaining to be sold: Subscription period has closed therefore no securities remain to be sold. false 4 424072 0 *Exchange rate of EUR 1 to USD 1.0896 (as reported by the ECB on May 28, 2015) 0 false Biotie Therapies Corp. /s/ Timo Veromaa Timo Veromaa President & CEO 2015-06-02